Of note, in mice crizotinib could be safely administered without any obvious toxicity to reach a concentration of 10 μM in plasma, lung tissues and tumors, which is the dose that is effectively inducing ICD hallmarks in cancer cells that lack ALK rearrangements. This evidence concerns the gene ALK and cancer.